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1079-79 The Impact of Aortic Manipulation on Neurological 
Outcomes After Coronary Artery Bypass Surgery: A 
Risk-Adjusted Study
Emmanouil I. Kapetanakis, Peter C. Hill, Mercedes K.C Dullum, Elizabeth Haile, Ammar 
S. Bafi, Steven W. Boyce, Kathleen R. Petro, Paul J. Corso, Washington Hospital Center, 
Washington, DC, MedStar Research Institute, Washington, DC
PURPOSE: The incidence of cerebrovascular accidents (CVA) after conventional Coro-
nary Artery Bypass Grafting (CABG) still remains high (2.5–4.6%). Cerebral embolization
by atherosclerotic plaque debris during aortic manipulation, is cited as a major underlying
mechanisms of post-operative stoke. Reducing stroke rates by eliminating aortic manipu-
lation is a driving concept in Off-Pump CABG (OPCAB) development. We investigated
the effect of aortic manipulation on post-operative neurological outcomes after CABG
surgery utilizing a risk-adjusted approach.
METHODS: From January 1998 to June 2002, 7,272 patients underwent isolated CABG
surgery via 3 levels of aortic manipulation; full aortic clamp application (On-Pump sur-
gery), (n=4,269), partial/side aortic clamp application (OPCAB surgery), (n=2,527) or a
"no-touch" technique (OPCAB surgery), (n=476). A risk-adjusted logistic regression anal-
ysis was performed to establish the likelihood of post-operative stroke with each tech-
nique. Pre-operative risk factors for stroke from the literature and those found significant
in a univariate model were used.
RESULTS: Patients with a fully applied aortic clamp were 1.6 times more likely to have a
stroke versus those without any aortic manipulation [95%CI=1.09-2.44,(p=0.02)]. Simi-
larly patients receiving full aortic clamping were 1.8 times more likely to develop post-
operative CVA than those with a partial/side aortic clamp applied [95%CI=1.19-
2.84,(p=0.01)]. In contrast patients who underwent partial/side aortic clamp surgery and
those operated on with the "no touch" approach showed no significant differences
[OR=0.9,(95%CI:0.59-1.34),(p=0.57)].
CONCLUSION: Recent studies have demonstrated lower post-operative CVA rates with
OPCAB surgery. While complete aortic occlusion during On-Pump CABG is a contribut-
ing mechanism of post-operative stroke, partial/side clamp application during OPCAB
surgery appears not to be.
1079-80 Improved Survival After Coronary Revascularization 
Without Cardiopulmonary Bypass Versus the 
Conventional Approach in High-Risk Patients
Sotiris C. Stamou, Kathleen A. Jablonski, Steven W. Boyce, Ammar S. Bafi, Peter C. Hill, 
Paul J. Corso, Georgetown University Hospital, Washington, DC, Washington Hospital 
Center, Washington, DC
Background: The premise of coronary revascularization without cardiopulmonary 
bypass (off-pump CABG) proposes that patient morbidity and, potentially, mortality can 
be reduced without compromising the excellent results of the conventional approach (on-
pump CABG), especially in high-risk patients. The aim of this study was to compare 
operative and 1 year mortality after off-pump vs. on-pump CABG in a subset of high-risk 
patients.
Methods: Between January 1, 2000, and December 31, 2000, 513 high-risk patients with 
a Parsonnet’s risk scores of 19.5 or higher underwent CABG; 38.6% (n=198) underwent 
On-pump CABG and 61.4% (n=315) had off-pump CABG. To adjust for potential 
confounders, a multivariate Cox regression model was constructed to assess the 
association between off-pump CABG and the risk of mortality. Any preoperative risk 
factor that was significantly related to on vs. off-pump CABG selection and/or risk factor 
that was related to mortality in the univariate analysis (p<0.1) was included in the 
multivariate model.
Results: Off-pump CABG was associated with a lower operative mortality than on-pump 
CABG (5% Vs. 12 %, p=0.02). The median follow-up for the on-pump CABG patients was 
12.2 (0-28.6) months and for the off pump 12.6 (0-26.4) months.  In the multivariate 
analysis, off-pump CABG emerged as an independent predictor of LOWER late mortality 
(Table). Advanced age, acute renal failure, acute myocardial infarction, and preoperative 
intraaortic balloon counterpulsation may also increase the mortality risk.
Conclusions: Compared to on-pump CABG, off-pump CABG can be performed with 
lower mortality in high-risk patients. Off-pump CABG may be a better revascularization 
option in this subset of patients.
1079-81 Preoperative Risk Factors for Post-Coronary Artery 
Bypass Graft Atrial Fibrillation
David Amar, Hao Zhang, Charles W. Hogue, Jr., Weiji Shi, Rod Passman, Peter Bach, 
Howard T. Thaler, Memorial Hospital/Weill Medical College of Cornell University, New 
York, NY, Washington University School of Medicine, St. Louis, MO
Background: Controversy exists as to which preoperative clinical and/or ECG character-
istics distinguish pts. who develop postoperative atrial fibrillation (AF). We examined the
usefulness of preoperative clinical and ECG variables previously shown to predict post-
CABG AF risk, in a large cohort of pts. Methods: Using a prospective database of 1553
consecutive pts. at one institution who were in sinus rhythm before surgery, had no previ-
ous cardiac surgery, and underwent standard CABG without concurrent valvular surgery,
we retrospectively analyzed clinical data and the preoperative standard 12-lead ECG.
Data are mean ±SD. Results: In-hospital sustained (> 5 min) postoperative AF occurred
in 508/1553 (33%) pts. and increased with age: 13% [< 55 yr], 29% [56-65 yr.], 45% [>66
yr.], P<0.0001. On univariate analysis age, prior AF, P-duration (lead II) and PR-interval
were significantly associated with AF occurrence (Table). Multivariate analysis showed
that age (P<0.0001, OR=1.3, per 5 yr increment, 95% CI, 1.2-1.4), prior AF (P<0.0001,
OR=3.7, 95%CI, 2.3-6.0) and P-duration > 110 ms (P=0.02, OR=1.3, 95% CI, 1.0-1.7)
were independently associated with AF risk. Conclusions: To our knowledge, this is the
largest study using preoperative ECG and clinical variables to predict post-CABG AF. Our
results show that greater age, prior history of AF and prolonged intraatrial conduction are
independently associated with postoperative AF risk. This information can be used to
guide prevention strategies for AF. 
1079-82 Intramyocardial Injection of Autologous Bone Marrow 
Cells Improves Myocardial Perfusion in Severe Ischemic 
Heart Disease: A 30-Day Assessment
Luís H. Gowdak, Isolmar Schettert, Marcelo C. Vieira, Carlos E. Rochitte, Cláudio 
Meneghetti, Luiz A. M César, Dalton Chamone, José E. Krieger, José A. Ramires, Sérgio 
A. de Oliveira, Heart Institute (InCor), University of São Paulo Medical School, São 
Paulo, Brazil
Background: Adult bone marrow cells (BMC) have the potential to contribute to angio-
genesis, myogenesis and matrix remodeling which might be explored therapeutically in
ischemic tissues. We tested the hypothesis that intramyocardial injection of autologous
BMC is safe and well-tolerated, and may help increase perfusion and the number of via-
ble cells in patients (pt) undergoing incomplete CABG for severe coronary artery disease
(CAD).
Methods: 10 pt (8 men), 59±1 years, with limiting angina and 3-vessel CAD, not optimal
candidates for complete CABG due to the extension of the disease were enrolled. Before
and 30-days after surgery, pt underwent laboratory tests, 24-hour ECG monitoring and
echocardiogram; myocardial perfusion (at rest/after pharmacological vasodilation) was
assessed in 17 cardiac segments with 201Tl scintigraphy (SPECT) and magnetic reso-
nance (MRI). BMC were obtained immediately prior to surgery, and the lymphomonocytic
fraction separated by density gradient centrifugation. During surgery, 4mL containing
approximately 13±3x107 BMC (CD34+=1.30±0.40%) were delivered by multiple injec-
tions in non-grafted areas of ischemic myocardium.
Results: Injected segments included the inferior (n=7), anterior (n=5) and lateral (n=1)
walls. No major complications or deaths occurred and the ejection fraction increased
from 0.45±0.03 to 0.51±0.02 (P=.003). As expected, 30-days vs. baseline MRI showed
reduction in total ischemic score (0.65±0.14 vs. 0.21±0.07; P=.01) but more interestingly,
the ischemic score of injected areas also reduced significantly (1.21±0.13 vs. 0.43±0.21;
P=.002). Similarly, cardiac scintigraphy showed improvement in perfusional defects in 10
out of the 13 injected segments. All patients remained free of angina.
Conclusions: In the short-term, intramyocardial injection of autologous BMC is safe and
well-tolerated, and may have contributed to increase myocardial perfusion in non-grafted
areas. This strategy could be used for myocardial angiogenesis in pt suffering from a
more advanced (diffuse) CAD not suitable for complete surgical revascularization pro-
vided these findings are confirmed in a larger randomized series of pt with longer follow-
up.
Risk Factors for late mortality
Hazard Ratio 95% Confidence 
Intervals
P
Off-pump CABG 0.60 0.37 to 0.96 0.03
Age> 75 years 1.72 1.07 to 2.74 0.02
Chronic Renal Failure 1.90 0.1.02 to 3.53 0.04
Hemodialysis 4.17 2.13 to 8.15 <0.01
Acute myocardial Infarction 1.91 1.17 to 3.12 0.01
Intraaortic balloon 
Counterpulsation
3.58 1.76 to 7.27 <0.01
Univariate Risk Factors for AF
AF (n=508) No AF (n=1045) P value
Age, yr 68±9 62±11 <0.0001
Male, n (%) 336 (66) 704 (67) 0.63
Prior AF, n (%) 57 (11) 27 (3) <0.0001
Prior MI, n (%) 265 (52) 525 (50) 0.48
COPD, n (%) 46 (9) 72 (7) 0.13
Beta-blockers, n (%) 239 (47) 547 (52) 0.05
Heart rate, bpm 72±14 72±15 0.55
PR-interval, ms 170±29 164±26 <0.0001
PR > 180 ms 135 (27) 242 (23) 0.14
P-duration, ms 117±17 115±18 0.02
P-duration > 110 ms 318 (63) 550 (53) 0.0002
